Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Oric Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 143
- +16 vs. Q4 2024
- Shares held
- 79.2M
- +8.87M (+12.6%) vs. Q4 2024
- Total value
- $442.0M
- −$125.7M (−22.1%) vs. Q4 2024
- New holders
- 33
- 49 more added
- Sold out
- 17
- 39 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $1.34B |
| Q1 2026 | 182 | $1.51B |
| Q4 2025 | 165 | $979.6M |
| Q3 2025 | 152 | $1.28B |
| Q2 2025 | 142 | $947.6M |
| Q1 2025 | 143 | $442.0M |
| Q4 2024 | 129 | $611.7M |
| Q3 2024 | 122 | $715.1M |
| Q2 2024 | 113 | $478.3M |
| Q1 2024 | 112 | $879.3M |
| Q4 2023 | 92 | $465.9M |
| Q3 2023 | 90 | $290.7M |
| Q2 2023 | 83 | $353.4M |
| Q1 2023 | 71 | $188.5M |
| Q4 2022 | 64 | $192.1M |
| Q3 2022 | 76 | $104.6M |
| Q2 2022 | 83 | $147.1M |
| Q1 2022 | 101 | $181.7M |
| Q4 2021 | 80 | $512.1M |
| Q3 2021 | 82 | $762.1M |
| Q2 2021 | 78 | $639.4M |
| Q1 2021 | 82 | $874.3M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Oric Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fred Alger Management, LLC | 178,722 | $997.3K | 0.01% | −40,554−18.5% | Reduced |
| Cantor Fitzgerald, L. P. | 200,000 | $1.12M | 0.04% | +177,296+780.9% | Added |
| Parkman Healthcare Partners LLC | 203,006 | $1.13M | 0.13% | +203,006 | New |
| Atom Investors LP | 210,706 | $1.18M | 0.14% | +134,064+174.9% | Added |
| Sphera Funds Management Ltd. | 234,834 | $1.31M | 0.32% | −38,379−14.0% | Reduced |
| DAFNA Capital Management LLC | 242,000 | $1.35M | 0.38% | +242,000 | New |
| Suvretta Capital Management, LLC | 255,000 | $1.42M | 0.06% | +255,000 | New |
| Bank of America Corp | 259,801 | $1.45M | 0.00% | +147,281+130.9% | Added |
| Goldman Sachs Group Inc | 294,784 | $1.64M | 0.00% | +24,778+9.2% | Added |
| Charles Schwab Investment Management Inc | 408,505 | $2.28M | 0.00% | −9,450−2.3% | Reduced |
| Schonfeld Strategic Advisors LLC | 426,902 | $2.38M | 0.02% | −297,417−41.1% | Reduced |
| UBS Asset Management Americas Inc | 509,179 | $2.84M | 0.00% | +473,600+1,331.1% | Added |
| Citadel Advisors LLC | 511,889 | $2.86M | 0.00% | +475,463+1,305.3% | Added |
| Northern Trust Corp | 546,746 | $3.05M | 0.00% | −7,247−1.3% | Reduced |
| OrbiMed Advisors LLC | 700,000 | $3.91M | 0.09% | +700,000 | New |
| Dimensional Fund Advisors LP | 727,830 | $4.06M | 0.00% | +10,642+1.5% | Added |
| Superstring Capital Management LP | 819,194 | $4.57M | 5.45% | −761,551−48.2% | Reduced |
| Euclidean Capital LLC | 989,410 | $5.52M | 2.07% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,007,575 | $5.62M | 0.32% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,022,790 | $5.71M | 0.00% | +72,268+7.6% | Added |
| Geode Capital Management, LLC | 1,305,991 | $7.29M | 0.00% | +27,278+2.1% | Added |
| Price T Rowe Associates Inc | 1,332,860 | $7.44M | 0.00% | +37,835+2.9% | Added |
| ArrowMark Colorado Holdings LLC | 1,346,189 | $7.51M | 0.12% | −49,163−3.5% | Reduced |
| MPM Oncology Impact Management LP | 1,399,514 | $7.81M | 1.34% | +1,399,514 | New |
| Frazier Life Sciences Management, L.P. | 1,410,193 | $7.87M | 0.36% | −2,478,045−63.7% | Reduced |
| Boxer Capital Management, LLC | 1,732,571 | $9.67M | 2.91% | 00.0% | Unchanged |
| Commodore Capital LP | 2,000,000 | $11.2M | 0.82% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 2,007,272 | $11.2M | 0.03% | +452,012+29.1% | Added |
| First Turn Management, LLC | 2,027,430 | $11.3M | 2.28% | +576,393+39.7% | Added |
| Silverarc Capital Management, LLC | 2,060,240 | $11.5M | 2.40% | +881,940+74.8% | Added |
| Vivo Capital, LLC | 2,080,450 | $11.6M | 1.54% | +802,632+62.8% | Added |
| NEA Management Company, LLC | 2,195,545 | $12.3M | 0.94% | +629,464+40.2% | Added |
| State Street Corp | 2,196,549 | $12.3M | 0.00% | +350,287+19.0% | Added |
| FMR LLC | 2,480,420 | $13.8M | 0.00% | +12,611+0.5% | Added |
| VR Adviser, LLC | 3,182,527 | $17.8M | 1.51% | −1,212,000−27.6% | Reduced |
| Vanguard Group Inc | 3,215,887 | $17.9M | 0.00% | +12,098+0.4% | Added |
| EcoR1 Capital, LLC | 3,418,068 | $19.1M | 1.13% | 00.0% | Unchanged |
| The Column Group LLC | 3,540,777 | $19.8M | 44.67% | 00.0% | Unchanged |
| Alkeon Capital Management LLC | 4,004,096 | $22.3M | 0.13% | +100,000+2.6% | Added |
| Nextech Invest, Ltd. | 5,285,714 | $29.5M | 6.85% | +5,285,714 | New |
| Pfizer Inc | 5,376,344 | $30.0M | 5.99% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,435,087 | $30.3M | 0.00% | +322,053+6.3% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 6,572,700 | $36.7M | 0.12% | +2,141,692+48.3% | Added |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,265,200−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −355,000−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −214,291−100.0% | Sold out |
| Monaco Asset Management SAM | 0 | $0 | 0.00% | −135,561−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −99,234−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −79,900−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −34,205−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −23,417−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −16,554−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −7,373−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −8,434−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −478−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Nextech Invest AG | – | – | – | – | Not filed |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |